Editorial Policies

Focus and Scope

Advances in Modern Oncology Research, AMOR, is a peer-reviewed, interdisciplinary, open-access journal that delivers original research articles, reviews and case reports; which covers basic, translational and clinical research that are significant in all aspects of modern oncology. With an emphasis on publishing high quality academic papers, detailing the latest scientific discovery and research in the field of oncology, AMOR aims to provide a communication and information exchange platform for a broad audience of cancer researchers including biomedical scientists, oncologists, pathologists, surgeons, and healthcare professionals. Articles from related fields that are interesting to a broad readership are particularly welcome.

 

Section Policies

Editorials

Provide opinion on an article or subject.

Unchecked Open Submissions Checked Indexed Unchecked Peer Reviewed

Trends in Oncology

Describe important observations, studies, or deductions with potential impact on healthcare policies and disease management.

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Reviews

Describe new developments, summarizes progress or collects published evidence for analysis.

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Original Research Articles

Primary mode of scientific communication; includes all reports of original research in oncology.

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Case Reports

Provide detailed report of the symptoms, signs, diagnosis, treatment, and follow-up of one (1), two (2), or up to three (3) clinical cases.

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Commentaries

Discuss interesting current topics in cancer research, with critical evaluations of published work.  

Checked Open Submissions Checked Indexed Unchecked Peer Reviewed

Correspondence

Letters to the editor, Responses from the authors, etc.

Checked Open Submissions Checked Indexed Unchecked Peer Reviewed

Perspectives

Describe new or potentially unconventional point-of-views on existing clinical observations.

Checked Open Submissions Checked Indexed Checked Peer Reviewed
 

Peer Review Process

All manuscripts submitted to AMOR undergo rigorous peer review.

  • Initial submission is reviewed by in house editors to ensure adherence to policies of AMOR.
  • The editor-in-chief decides on the manuscript to be sent out for review process and assigns the manuscript to one of the associate/section editors according to the topic.
  • The associate editor chooses the reviewers from within the editorial board or external experts depending on the topic.
  • After evaluations by the reviewers have been received, the associate/section editor makes one of the following recommendations: accept, accept with minor revision, accept with major revision and reject. The editor-in-chief makes a final decision.
  • If decision is minor revision, the authors have 15 days to resubmit the revised manuscript.
  • If decision is major revision, the authors have 40 days to resubmit the revised manuscript.
  • Upon resubmission, the same procedure is applied as for the initial submission. .
  • Authors may appeal for a rejected submission. Appeal requests must be made in writing to amor@piscomed.com with detailed reasons for the appeal and point by point responses to the reviewers’ remarks. Decisions on appeals are final without exception.

 

Note: Author may suggest up to six academically qualified reviewers to review your submitted manuscript. Please insert the current contact details of the reviewer and state the reason for recommendation under the "Comments for the Editor" section in the last section of Step 1 during submission. However, please take note that this does not confirm that the recommended reviewers will be selected to review your manuscript.

 

 

Guidelines for Peer Reviewers


 

1.1) Investigate the journal’s content

• Visit AMOR’s homepage to get to know the journal’s published content and house style.
• Refer to the instructions for authors to see if the paper meets the submission criteria of the journal.


2.1) Make an assessment
• Complete the review form provided to indicate the relative strengths or weaknesses of the paper.
• Provide positive feedback and constructive criticism to improve the quality of the manuscript.


2.2) Answer key questions
Advice as a reviewer should be based on a few main factors such as:
• Originality
• Presentation
• Relevance
• Significance of the manuscript’s subject matter to the readership of the journal
• Subject matter fits the scope of the journal
• All the relevant sections in the manuscript are present and adequately written, including abstract and conclusion. 
• Manuscript is written in English
• Accuracy
• Length of paper
• Appropriate referencing


2.3) Make a recommendation
Once the paper has been assessed, a recommendation will need to be made to the editor regarding publication. The peer reviewer may choose one of the following as their decision:
• Accept – suitable for publication
• Revisions required – minor revisions
• Resubmit for review – major revisions
• Reject – not suitable for publication


2.4) Provide detailed comments
In the review form there will be a section for comments for authors and editors. This section can be used to seek clarification on any ambiguous points, for further elaboration, to improve quality and the overall quality of presentation.

 

Note: Peer reviewers must handle submitted material in confidence and disclose any potential competing interests before agreeing to review a submission. Please refer to Code of Conduct for Journal Editors for more best practice guidelines from COPE.

 

Publication Frequency

The publication frequency of Advances in Modern Oncology Research is bi-monthly.

 

Open Access Policy

Author(s) shall retain the copyright of their work, but grant to the Publisher a license to publish. The license to publish shall be Attribution-Non Commercial 4.0 International (CC BY-NC 4.0), which allows for the copying, distribution, and transmission of the work, provided the correct attribution of the original creator is stated. This broad license intends to facilitate free access to, as well as the unrestricted reuse of, original works of all types. This ensures that the published work is freely and openly available in perpetuity.

 

Editorial Policies

The journal will not accept a manuscript that has been published or is under consideration for publication in any other journal. The author needs to notify the journal if the data presented in the manuscript has been ever presented in conferences or other similar forums. The author is required to check the submission checklist to ensure that these criteria are fulfilled.

 

Conflict of Interest

The author(s) should hold responsibility in declaring any conflict of interest with respect to their work. The author(s) must provide details of any relationship with financial bodies or funding agencies that might influence the results or interpretation of their manuscript. All authors, members, reviewers and editors must disclose any association that poses a conflict of interest in connection with the manuscript. The corresponding author must download and complete the ICMJE Conflict of Interest Form on behalf of all the authors regarding potential conflicts of interest, and submit the form in Step 4 during the article submission process. Conflict of Interest declarations or statements are published in each manuscript as provided by the author(s).

 

Statement of Informed Consent

Patients have a right to their privacy and it should not be violated without informed consent. Authors should protect their patients’ right to privacy by requesting written consent from the patients or patient’s guardian to publish his/her data, including photographs and radiological images, prior to publication. To protect the patient’s anonymity, clinical photographs should be cropped appropriately (or eye bars can be utilised) to ensure that the patient is unrecognizable. Other details such as race, ethnicity, religion or cultural background of a subject under study should be mentioned only when it is believed to have an impact on the course of the disease and/or treatment discussed in the study. If changing the biographical details and/or identifying characteristics is done in order to protect anonymity, authors should provide assurance that the changes do not falsify the scientific meaning of a manuscript/report. The informed consent form/agreement should be included in as a supplementary document of a manuscript during submission. Statements of informed consents are published in each manuscript as provided by the author(s).

 

Human and Animal Rights Statement

Humans: When the submitted manuscript involves experiments performed on human subjects, including healthy volunteers, authors should adhere to the principles of the Declaration of Helsinki, as revised in 2000 and 2008 and indicate whether the procedures followed were in accordance with the ethical standards of the author's Institutional Review Board or Research Ethics Committee. Any possible adverse consequences of the work on the ecosystem, population or individual organisms must be weighed against the possible gains in knowledge and its practical applications.

 

Animals: When reporting experiments involving animals, authors should indicate whether relevant international, national, and/or institutional guidelines for the care and use of laboratory animals were conducted accordingly. All animal work must specifically require authors to include details of animal welfare (such as species, number, gender, age, weight, housing conditions, welfare, training and the fate of the animals at the end of the experiment) and relevant details of steps taken to ameliorate suffering in all work. For studies involving client-owned animals, author(s) must possess (and attach) a document of informed client consent and adhere to a high standard (best practise) of veterinary care.  These details should be included in the Materials and Methods section of the article.

 

Advances in Modern Oncology Research encourages authors to submit the registration number and name of clinical trial reports.

 

Code of Ethics and Practices

PiscoMed Publishing requests all members involved in the journal publishing process to adhere to the “Code of Conduct for Journal Editors” and “Code of Conduct for Journal Publishers” as stipulated by COPE (Committee on Publication Ethics).

PiscoMed Publishing adheres to the guidelines and best practices which include Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals from the International Committee of Medical Journals  Editors (ICMJE) and the Principles of Transparency and Best Practice in Scholarly Publishing developed by Committee on Publication Ethics (COPE), Directory of Open Access Journals (DOAJ), Open Access Scholarly Publishers Association (OASPA) and World Association of Medical Editors (WAME).

All complaints submitted to the journal would be addressed promptly according to the procedure set out in the COPE flowchart on complaints. The complainant may direct all enquiries and correspondence to the Editorial Office.

 

Plagiarism Detection

The journal will not accept manuscripts that are plagiarized under any circumstances. The journal will verify the originality of submitted manuscripts using iThenticate, the plagiarism detection software.

If a manuscript uses a text copied directly from another source, this text must be written in quotation marks and the original source must be cited. If any kind of plagiarism is detected during the review process, the manuscript will be rejected.

Authors and researchers can also use iThenticate to screen their work before submission by visiting http://www.ithenticate.com.

 

Language

All articles should be written in English—either British or American as long as consistency is observed. 

 

Units of Measurement

Units of measurement should be presented simply and concisely using System International (SI) units.

 

Advertising Policies

Advances in Modern Oncology Research abide by the best practice guidelines on commercial considerations as stipulated by COPE’s Code of Conduct for Journal Editors. The advertising terms will apply to all online, print and e-mail advertisements which are submitted to the journal and accepted for publication. By submitting an advertisement to the journal, the advertiser agrees to be bound by these terms and conditions. Advertisements submitted for publication must comply with Singaporean and International laws, and are subject to approval from the Editorial Office. The journal reserves the right to refuse any advertisements at its sole discretion for any reason whatsoever, including without limitation for offensive or inappropriate content. The advertiser retains copyright to the advertisement but grants the journal a worldwide, irrevocable, non-exclusive, and transferable license to reproduce the advertisement, including any trademarks therein, and including without limitation in any future archive or database in any medium, now known or later invented.